Bloomberg News

Grifols Sees Annual Savings of $230 Million After 2015

October 17, 2011

(Corrects currency of capital expenditure to dollars after Grifols corrected regulatory filing.)

Oct. 17 (Bloomberg) -- Grifols SA expects to generate annual synergies of $230 million beyond 2015 after its merger with Talecris Biotherapeutics Holdings Corp, the company said in

a presentation filed to regulators today.

Grifols, which holds an investor’s day in Barcelona Oct. 17

and Oct. 18, said total capital expenditure from 2011 to 2015 will be $964 million, while integration costs will be $70 million to 2014, lower than the initial estimate, the company said.

To contact the editor responsible for this story: Emma Ross-Thomas at

The Good Business Issue
blog comments powered by Disqus